All data are based on the daily closing price as of August 5, 2025
a

ASKA Pharmaceutical Holdings

4886.TSE
15.78 USD
-0.94
-5.62%

Overview

Last close
15.78 usd
Market cap
447.57M usd
52 week high
17.31 usd
52 week low
11.96 usd
Target price
17.28 usd

Valuation

P/E
12.9412
Forward P/E
N/A
Price/Sales
1.0295
Price/Book Value
1.0697
Enterprise Value
519.36M usd
EV/Revenue
1.0852
EV/EBITDA
8.1983

Key financials

Revenue TTM
434.75M usd
Gross Profit TTM
212.40M usd
EBITDA TTM
51.38M usd
Earnings per Share
1.22 usd
Dividend
0.37 usd
Total assets
674.32M usd
Net debt
2.01M usd

About

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. It operates through three segments: The Pharmaceutical Business, The Animal Health Business, and The Overseas Business. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. In addition, the company manufactures and sells ethical pharmaceutical overseas. ASKA Pharmaceutical Holdings Co.,Ltd. was founded in 1920 and is headquartered in Tokyo, Japan.
  • Symbol
    4886.TSE
  • Exchange
    TSE
  • Isin
    JP3119660003
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.aska-pharma-hd.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top